Nuveen Real Asset Income and Growth Fund
JRI
$12.49
$0.151.22%
Weiss Ratings | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C- | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Company Info | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Nuveen Fund Advisors, LLC. | |||
Manager/Tenure (Years) | Brenda A. Langenfeld (9), Tryg T. Sarsland (9), Benjamin T. Kerl (6) | |||
Website | http://www.nuveen.com | |||
Fund Information | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Nuveen Real Asset Income and Growth Fund | |||
Category | Global Allocation | |||
Sub-Category | Allocation Miscellaneous | |||
Prospectus Objective | Growth and Income | |||
Inception Date | Apr 25, 2012 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | -- | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 5.38% | |||
Dividend | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 6.05% | |||
Asset Allocation | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 0.50% | |||
Stock | 49.30% | |||
U.S. Stock | 24.94% | |||
Non-U.S. Stock | 24.36% | |||
Bond | 32.54% | |||
U.S. Bond | 25.27% | |||
Non-U.S. Bond | 7.27% | |||
Preferred | 13.71% | |||
Convertible | 3.22% | |||
Other Net | 0.72% | |||
Price History | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 2.58% | |||
30-Day Total Return | -0.35% | |||
60-Day Total Return | 0.51% | |||
90-Day Total Return | 0.91% | |||
Year to Date Total Return | 3.17% | |||
1-Year Total Return | 13.56% | |||
2-Year Total Return | 16.25% | |||
3-Year Total Return | 3.89% | |||
5-Year Total Return | 59.03% | |||
Price | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | $11.26 | |||
1-Month High Price | $13.05 | |||
52-Week Low Price | $11.13 | |||
52-Week Low Price (Date) | May 29, 2024 | |||
52-Week High Price | $13.67 | |||
52-Week High Price (Date) | Sep 30, 2024 | |||
NAV | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $13.07 | |||
1-Month Low NAV | $12.24 | |||
1-Month High NAV | $13.37 | |||
52-Week Low NAV | $12.24 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $14.59 | |||
52-Week High Price (Date) | Sep 24, 2024 | |||
Beta / Standard Deviation | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Standard Deviation | 17.46 | |||
Balance Sheet | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 364.09M | |||
Operating Ratios | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 2.09% | |||
Turnover Ratio | 80.00% | |||
Performance | JRI-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 15.49% | |||
Last Bear Market Total Return | -12.73% | |||